Showing results (151-160 of 214) with videos related to
Sort By:
Pageof 22
The FEBS Journal|July 11, 2019
Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approachMaria Luisa Di Paolo, Giorgio Cozza, Andrea Milelli, et al.Biochimica Et Biophysica Acta. General Subjects|August 6, 2017
Covalently bound DNA on naked iron oxide nanoparticles: Intelligent colloidal nano-vector for cell transfectionMassimiliano Magro, Tiziana Martinello, Emanuela Bonaiuto, et al.Pharmacology & Therapeutics|August 23, 2002
Toward the rational design of protein kinase casein kinase-2 inhibitorsStefania Sarno, Stefano Moro, Flavio Meggio, et al.The Journal of Biological Chemistry|March 30, 2005
Thrombin-induced tyrosine phosphorylation of HS1 in human platelets is sequentially catalyzed by Syk and Lyn tyrosine kinases and associated with the cellular migration of the proteinAnna Maria Brunati, Renzo Deana, Alessandra Folda, et al.Biochemical and Biophysical Research Communications|June 17, 2006
Sic1 is phosphorylated by CK2 on Ser201 in budding yeast cellsPaola Coccetti, Vittoria Zinzalla, Gabriella Tedeschi, et al.Biochimica Et Biophysica Acta|November 13, 2008
Grp94 is Tyr-phosphorylated by Fyn in the lumen of the endoplasmic reticulum and translocates to Golgi in differentiating myoblastsMartina Frasson, Maurizio Vitadello, Anna Maria Brunati, et al.Plos One|April 16, 2015
ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitorsFederica Lovisa, Giorgio Cozza, Andrea Cristiani, et al.The Biochemical Journal|August 7, 2003
Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activityFranc Llorens, Nerea Roher, Francesc A Miró, et al.Journal of Proteome Research|September 10, 2010
Proteomic analysis of clonal interstitial aortic valve cells acquiring a pro-calcific profileElisa Bertacco, Renato Millioni, Giorgio Arrigoni, et al.Nature Communications|June 19, 2015
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumoursMadhuri Kalathur, Alberto Toso, Jingjing Chen, et al.Pageof 22